Vaccination, squalene and anti-squalene antibodies: Facts or fiction?
- 31 December 2009
- journal article
- review article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 21 (2) , 70-73
- https://doi.org/10.1016/j.ejim.2009.12.001
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted VaccineNew England Journal of Medicine, 2009
- Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in micePLoS Currents, 2009
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 AdjuvantThe Pediatric Infectious Disease Journal, 2009
- Biological and Pharmacological Activities of Squalene and Related Compounds: Potential Uses in Cosmetic DermatologyMolecules, 2009
- MF59®‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxisInfluenza and Other Respiratory Viruses, 2008
- Vaccine adjuvants: The dream becomes realHuman Vaccines, 2008
- Safety of MF59™ adjuvantVaccine, 2008
- Gulf War Syndrome: A Toxic Exposure? A Systematic ReviewNeurologic Clinics, 2005
- Antibodies to Squalene in Gulf War SyndromeExperimental and Molecular Pathology, 2000
- Sterol, Structure and Membrane FunctionCritical Reviews in Biochemistry, 1983